BeStock  
Markets › Compare › ADMA vs VKTX

ADMA vs VKTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ADMA · ADMA Biologics$13.17 ▼ 1.27%
VKTX · Viking Therapeutics$24.77 ▼ 4.14%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

375982104126Nov 24, '25May 26, '26Nov 20, '26
  • ADMA -28.1%
  • VKTX -28.5%

Head to head

MetricADMAVKTX
Price$13.17$24.77
Change today▼ 1.27%▼ 4.14%
Market cap$2.92B$3.16B
Return, 3 months+37.9%-25.5%
Return, year to date-27.8%-29.6%
Return, 1 year-23.3%-27.7%
P/E (TTM)17.1–
P/B6.75.4
P/E percentile vs own 5y69th81st
Dividend yield––
Revenue growth (YoY, latest qtr)+5.1%–
Net profit growth (YoY)+36.9%-101.8%
Gross margin68.5%–
Operating margin44.9%–
Net margin35.1%–
Return on equity41.9%-96.4%
Analyst target vs. price+26.6%+277.6%
Analyst buy share67%94%
RSI (14)6241
30-day volatility77.7%75.0%
Max drawdown, 1 year-62.7%-42.5%
Trend readStrong uptrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • VKTX is the largest of the group by market value.
  • ADMA has returned the most over the past year.
  • VKTX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top